rc 3095 has been researched along with gastrin releasing peptide (14-27) in 4 studies
Studies (rc 3095) | Trials (rc 3095) | Recent Studies (post-2010) (rc 3095) | Studies (gastrin releasing peptide (14-27)) | Trials (gastrin releasing peptide (14-27)) | Recent Studies (post-2010) (gastrin releasing peptide (14-27)) |
---|---|---|---|---|---|
108 | 2 | 26 | 21 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, RZ; Jaworek, J; Konturek, PK; Konturek, SJ; Schally, AV | 1 |
Cai, RZ; Groot, K; Pinski, J; Radulovic, S; Schally, AV; Yano, T | 1 |
Cai, RZ; Pinski, J; Radulovic, S; Rekasi, Z; Schally, AV; Yano, T | 1 |
Groot, K; Halmos, G; Schally, AV; Szepeshazi, K | 1 |
4 other study(ies) available for rc 3095 and gastrin releasing peptide (14-27)
Article | Year |
---|---|
Actions of novel bombesin receptor antagonists on pancreatic secretion in rats.
Topics: Amino Acid Sequence; Amylases; Animals; Bombesin; Gastrin-Releasing Peptide; In Vitro Techniques; Molecular Sequence Data; Pancreas; Peptide Fragments; Peptides; Rats; Receptors, Bombesin; Receptors, Neurotransmitter | 1992 |
Endocrine effects of new bombesin/gastrin-releasing peptide antagonists in rats.
Topics: Amino Acid Sequence; Animals; Blood Glucose; Bombesin; Endocrine Glands; Gastrin-Releasing Peptide; Gastrins; Glucagon; Growth Hormone; Insulin; Male; Molecular Sequence Data; Peptide Fragments; Peptides; Rats; Rats, Sprague-Dawley | 1992 |
High potency of a new bombesin antagonist (RC-3095) in inhibiting serum gastrin levels; comparison of different routes of administration.
Topics: Administration, Inhalation; Animals; Bombesin; Gastrin-Releasing Peptide; Gastrins; Injections, Intravenous; Injections, Subcutaneous; Male; Peptide Fragments; Peptides; Radioimmunoassay; Rats; Rats, Sprague-Dawley | 1992 |
Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters.
Topics: Animals; Body Weight; Bombesin; Carcinoma; Cricetinae; Dose-Response Relationship, Drug; Down-Regulation; Epidermal Growth Factor; ErbB Receptors; Female; Gastrin-Releasing Peptide; Gastrins; Growth Hormone; Insulin-Like Growth Factor I; Mesocricetus; Nitrosamines; Pancreatic Neoplasms; Peptide Fragments; Peptides; Receptors, Bombesin; Receptors, Neurotransmitter | 1993 |